Healthcare Stocks
Healthcare covers pharmaceuticals, biotech, medical devices, managed care, and hospitals. Patent cliffs, regulatory risk, and binary clinical outcomes distort reported earnings, so we lean on cash-based valuation (Price/FCF, EV/EBITDA) and multi-year revenue durability when ranking this sector. Biotech pre-revenue names often screen poorly on Value — that's by design.
Top 50 Healthcare Stocks by StockRank
| # | Ticker | Company | Mkt Cap | Score | Q | V | M |
|---|---|---|---|---|---|---|---|
| 1 | 8049.HK | Jilin Province Huinan Changlong Bio-pharmacy Company Limited | $168M | 100 | 80 | 96 | 77 |
| 2 | 096760.KS | JW Holdings Corporation | $200M | 100 | 75 | 94 | 67 |
| 3 | 2279.HK | Yonghe Medical Group Co., Ltd. | $140M | 100 | 77 | 92 | 73 |
| 4 | HRMY | Harmony Biosciences Holdings, Inc. | $2.3B | 100 | 81 | 72 | 85 |
| 5 | PHIL.MI | Philogen S.p.A. | $1.1B | 100 | 93 | 83 | 60 |
| 6 | VLS.AX | Vita Life Sciences Limited | $109M | 100 | 86 | 75 | 77 |
| 7 | 001540.KQ | Ahn-Gook Pharmaceutical Co., Ltd. | $89M | 100 | 70 | 89 | 74 |
| 8 | 1J5.SI | Hyphens Pharma International Limited | $87M | 100 | 75 | 84 | 73 |
| 9 | HLUN-A.CO | H. Lundbeck A/S | $6.3B | 100 | 74 | 82 | 78 |
| 10 | ASCN.SW | Ascom Holding AG | $218M | 100 | 84 | 81 | 65 |
| 11 | IRWD | Ironwood Pharmaceuticals, Inc. | $682M | 100 | 86 | 75 | 71 |
| 12 | 1830.HK | Perfect Medical Health Management Limited | $210M | 100 | 80 | 81 | 67 |
| 13 | 2877.HK | China Shineway Pharmaceutical Group Limited | $821M | 100 | 76 | 94 | 60 |
| 14 | 8432.TWO | TSH Biopharm Corporation Limited | $61M | 100 | 82 | 86 | 60 |
| 15 | DRW8.DE | Drägerwerk AG & Co. KGaA | $1.8B | 100 | 71 | 84 | 72 |
| 16 | GXH.NZ | Green Cross Health Limited | $166M | 100 | 63 | 80 | 85 |
| 17 | 0157.KL | Focus Point Holdings Berhad | $79M | 100 | 77 | 86 | 63 |
| 18 | 7792.T | Colan Totte.Co.,Ltd. | $85M | 100 | 87 | 75 | 63 |
| 19 | 6782.TW | Visco Vision Inc. | $455M | 99 | 81 | 65 | 77 |
| 20 | BION.SW | BB Biotech AG | $3.8B | 99 | 90 | 73 | 62 |
| 21 | NUTX | Nutex Health Inc. | $1.3B | 99 | 84 | 78 | 62 |
| 22 | 2348.HK | Dawnrays Pharmaceutical (Holdings) Limited | $192M | 99 | 64 | 94 | 65 |
| 23 | 3600.HK | Modern Dental Group Limited | $977M | 99 | 81 | 69 | 72 |
| 24 | DRW3.DE | Drägerwerk AG & Co. KGaA | $2.4B | 99 | 71 | 76 | 75 |
| 25 | KRK.WA | Krka, d. d. | $9.2B | 99 | 85 | 58 | 79 |
| 26 | M12.DE | M1 Kliniken AG | $399M | 99 | 78 | 74 | 71 |
| 27 | BVXP.L | Bioventix PLC | $122M | 99 | 93 | 65 | 63 |
| 28 | NXG.V | NexgenRx Inc. | $31M | 99 | 84 | 53 | 85 |
| 29 | 3034.T | Qol Holdings Co., Ltd. | $593M | 99 | 64 | 82 | 74 |
| 30 | 6678.T | Techno Medica Co., Ltd. | $85M | 99 | 77 | 85 | 57 |
| 31 | HLUN-B.CO | H. Lundbeck A/S | $6.4B | 99 | 74 | 81 | 64 |
| 32 | 6823.T | Rion Co., Ltd. | $255M | 99 | 80 | 79 | 59 |
| 33 | BRM.DE | Bristol-Myers Squibb Company | $136.6B | 99 | 73 | 64 | 82 |
| 34 | ACL.AX | Australian Clinical Labs Limited | $374M | 99 | 71 | 70 | 76 |
| 35 | BBZA.DE | BB Biotech AG | $3.1B | 99 | 90 | 58 | 69 |
| 36 | BOI.PA | Boiron SA | $527M | 99 | 72 | 82 | 63 |
| 37 | 1345.HK | Shanghai Pioneer Holding Ltd | $331M | 99 | 74 | 68 | 75 |
| 38 | 1681.HK | Consun Pharmaceutical Group Limited | $1.5B | 99 | 87 | 81 | 48 |
| 39 | BMY | Bristol-Myers Squibb Company | $136.0B | 99 | 74 | 65 | 77 |
| 40 | FLRY3.SA | Fleury S.A. | $2.0B | 99 | 60 | 79 | 77 |
| 41 | MED.DE | MEDICLIN Aktiengesellschaft | $305M | 99 | 59 | 82 | 74 |
| 42 | NTC.JO | Netcare Limited | $1.3B | 99 | 68 | 77 | 70 |
| 43 | 9265.T | Yamashita Health Care Holdings,Inc. | $60M | 99 | 68 | 74 | 73 |
| 44 | 1526.HK | Rici Healthcare Holdings Limited | $164M | 99 | 70 | 93 | 51 |
| 45 | 340570.KQ | T&L Co., Ltd. | $337M | 99 | 83 | 68 | 64 |
| 46 | EXEL | Exelixis, Inc. | $13.5B | 99 | 89 | 52 | 74 |
| 47 | PBYI | Puma Biotechnology, Inc. | $468M | 99 | 85 | 61 | 68 |
| 48 | PRM.MC | Prim, S.A. | $263M | 99 | 77 | 72 | 66 |
| 49 | RIGL | Rigel Pharmaceuticals, Inc. | $868M | 99 | 81 | 71 | 62 |
| 50 | 2219.HK | Chaoju Eye Care Holdings Limited | $223M | 98 | 62 | 91 | 61 |
Other Sectors
Technology
Software, semiconductors, cloud, and platform businesses ranked by Quality, Value, and Momentum.
Financial Services
Banks, insurers, asset managers, and exchanges ranked on Quality, Value, and Momentum.
Consumer Cyclical
Autos, retail, travel, and apparel — cyclical consumer names ranked by MoatMap.
Consumer Defensive
Food, beverage, household products, and discount retail — stable demand businesses.
Industrials
Aerospace, machinery, defence, transportation, and logistics ranked by Quality, Value, and Momentum.
Energy
Oil & gas, refining, pipelines, and energy services ranked by MoatMap.
Basic Materials
Mining, metals, chemicals, and building materials ranked on Quality, Value, and Momentum.
Utilities
Regulated electric, gas, water, and renewable utilities ranked by MoatMap.
Real Estate
REITs across residential, commercial, industrial, and data centre property ranked by MoatMap.
Communication Services
Telecom, media, interactive entertainment, and internet platforms ranked by MoatMap.